NextPlat Corp (NASDAQ:NXPL – Get Free Report) was the recipient of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 17,700 shares, a decrease of 20.3% from the October 31st total of 22,200 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average trading volume of 43,100 shares, the days-to-cover ratio is currently 0.4 days.
Institutional Investors Weigh In On NextPlat
An institutional investor recently bought a new position in NextPlat stock. Omnia Family Wealth LLC bought a new position in shares of NextPlat Corp (NASDAQ:NXPL – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 93,429 shares of the company’s stock, valued at approximately $132,000. Omnia Family Wealth LLC owned 0.49% of NextPlat as of its most recent SEC filing. Institutional investors and hedge funds own 1.30% of the company’s stock.
NextPlat Stock Performance
Shares of NXPL traded down $0.06 during midday trading on Friday, hitting $0.79. 45,965 shares of the stock traded hands, compared to its average volume of 39,836. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.04 and a current ratio of 3.70. NextPlat has a 1-year low of $0.75 and a 1-year high of $2.68. The business’s 50 day moving average price is $1.13 and its two-hundred day moving average price is $1.15. The firm has a market capitalization of $20.51 million, a PE ratio of -1.16 and a beta of 0.92.
NextPlat Company Profile
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
See Also
- Five stocks we like better than NextPlat
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Quiet Period Expirations Explained
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Transportation Stocks Investing
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.